Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Retinoblastoma Treatment Market Report by Type (Non-Hereditary Retinoblastoma, Hereditary Retinoblastoma), Treatment Type (Surgery, Radiation Therapy, Laser Therapy (Photocoagulation), Cryotherapy, Thermotherapy, Chemotherapy, Opthalmic Artery Infusion Chemotherapy, High-Dose Chemotherapy and Stem Cell Transplant), Type of Staging (Intraocular Retinoblastoma, Extraocular Retinoblastoma), Application (Hospitals, Cancer Institutes, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A6732
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Retinoblastoma Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Non-Hereditary Retinoblastoma
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hereditary Retinoblastoma
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Surgery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Radiation Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Laser Therapy (Photocoagulation)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cryotherapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Thermotherapy
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Chemotherapy
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Opthalmic Artery Infusion Chemotherapy
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 High-Dose Chemotherapy and Stem Cell Transplant
7.8.1 Market Trends
7.8.2 Market Forecast
8 Market Breakup by Type of Staging
8.1 Intraocular Retinoblastoma
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Extraocular Retinoblastoma
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cancer Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bristol Myers Squibb Company
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Pfizer Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Teva Canada Limited (Teva Pharmaceutical Industries Ltd.)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
List of Figures
Figure 1: Global: Retinoblastoma Treatment Market: Major Drivers and Challenges
Figure 2: Global: Retinoblastoma Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Retinoblastoma Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Retinoblastoma Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Retinoblastoma Treatment Market: Breakup by Treatment Type (in %), 2023
Figure 6: Global: Retinoblastoma Treatment Market: Breakup by Type of Staging (in %), 2023
Figure 7: Global: Retinoblastoma Treatment Market: Breakup by Application (in %), 2023
Figure 8: Global: Retinoblastoma Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Retinoblastoma Treatment (Surgery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Retinoblastoma Treatment (Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Retinoblastoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Retinoblastoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Retinoblastoma Treatment (Cryotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Retinoblastoma Treatment (Cryotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Retinoblastoma Treatment (Thermotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Retinoblastoma Treatment (Thermotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Retinoblastoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Retinoblastoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Retinoblastoma Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Retinoblastoma Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Retinoblastoma Treatment (Cancer Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Retinoblastoma Treatment (Cancer Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Retinoblastoma Treatment (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Retinoblastoma Treatment (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: North America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: North America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: United States: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: United States: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Canada: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Canada: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Asia-Pacific: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Asia-Pacific: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: China: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: China: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Japan: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Japan: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: India: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: India: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: South Korea: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: South Korea: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Australia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Australia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Indonesia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Indonesia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Europe: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Europe: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Germany: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Germany: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: France: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: France: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: United Kingdom: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: United Kingdom: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Italy: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Italy: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Spain: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Spain: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Russia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Russia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Latin America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Latin America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Brazil: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Brazil: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Mexico: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Mexico: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Middle East and Africa: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Middle East and Africa: Retinoblastoma Treatment Market: Breakup by Country (in %), 2023
Figure 87: Middle East and Africa: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Global: Retinoblastoma Treatment Industry: Drivers, Restraints, and Opportunities
Figure 89: Global: Retinoblastoma Treatment Industry: Value Chain Analysis
Figure 90: Global: Retinoblastoma Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Retinoblastoma Treatment Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Retinoblastoma Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
Table 4: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type of Staging (in Million US$), 2024-2032
Table 5: Global: Retinoblastoma Treatment Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Retinoblastoma Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Retinoblastoma Treatment Market: Competitive Structure
Table 8: Global: Retinoblastoma Treatment Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More